ID

36545

Beschrijving

A Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy of Tocilizumab+Non-biological DMARD in Reducing Synovitis as Measured by MRI at 12 Weeks After Initiation of Treatment in Patients With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Non-biological DMARDs; ODM derived from: https://clinicaltrials.gov/show/NCT01034397

Link

https://clinicaltrials.gov/show/NCT01034397

Trefwoorden

Versies (2)
  1. 19-01-19 19-01-19 -
  2. 21-05-19 21-05-19 -
Houder van rechten

Hoffmann-La Roche

Geüploaded op

21 mei 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Tocilizumab and non-biological DMARD in Rheumatoid Arthritis NCT01034397

Engels

Eligibility Criteria

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/=18 years of age
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
moderate to severe rheumatoid arthritis of >/=6 months duration
Beschrijving

Rheumatoid Arthritis Severity and Duration

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0449238
UMLS CUI [2,1]
C0003873
UMLS CUI [2,2]
C1319166
synovitis (swollen and tender joint) in the wrist of the dominant hand
Beschrijving

Synovitis in wrist of dominant hand

Datatype

boolean

Alias
UMLS CUI [1,1]
C0039103
UMLS CUI [1,2]
C1322271
UMLS CUI [1,3]
C0449722
non-biologic DMARDs at stable dose for >/=12 weeks prior to baseline
Beschrijving

Non-biologic DMARDs stable dose

Datatype

boolean

Alias
UMLS CUI [1,1]
C4054347
UMLS CUI [1,2]
C0205360
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0332185
oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
Beschrijving

Oral Corticosteroids stable dose

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [1,4]
C0442027
UMLS CUI [1,5]
C0332185
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than RA
Beschrijving

Rheumatic disease other than RA

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0035435
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C0003873
history of or current inflammatory joint disease other than RA
Beschrijving

History of or current inflammatory joint disease other than RA

Datatype

boolean

Alias
UMLS CUI [1,1]
C0683381
UMLS CUI [1,2]
C1705847
UMLS CUI [1,3]
C0003873
UMLS CUI [1,4]
C0262926
UMLS CUI [2,1]
C0683381
UMLS CUI [2,2]
C1705847
UMLS CUI [2,3]
C0003873
UMLS CUI [2,4]
C0521116
functional class IV (ACR classification)
Beschrijving

ACR

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0598463
UMLS CUI [1,3]
C0456387
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
Beschrijving

Intraarticular or Parenteral Corticosteroids

Datatype

boolean

Alias
UMLS CUI [1,1]
C4039704
UMLS CUI [1,2]
C0332185
UMLS CUI [2,1]
C2064783
UMLS CUI [2,2]
C0332185
previous treatment with a biologic agent for RA
Beschrijving

Previous biologic agent

Datatype

boolean

Alias
UMLS CUI [1,1]
C1531518
UMLS CUI [1,2]
C0003873
Terug naar het begin van de pagina

Similar models

Eligibility Criteria

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Criteria
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult patients, >/=18 years of age
boolean
C0001779 (UMLS CUI [1])
Rheumatoid Arthritis Severity and Duration
Item
moderate to severe rheumatoid arthritis of >/=6 months duration
boolean
C0003873 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C1319166 (UMLS CUI [2,2])
Synovitis in wrist of dominant hand
Item
synovitis (swollen and tender joint) in the wrist of the dominant hand
boolean
C0039103 (UMLS CUI [1,1])
C1322271 (UMLS CUI [1,2])
C0449722 (UMLS CUI [1,3])
Non-biologic DMARDs stable dose
Item
non-biologic DMARDs at stable dose for >/=12 weeks prior to baseline
boolean
C4054347 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0332185 (UMLS CUI [1,4])
Oral Corticosteroids stable dose
Item
oral corticosteroids at stable dose for at least 25 out of 28 days prior to baseline
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0442027 (UMLS CUI [1,4])
C0332185 (UMLS CUI [1,5])
Item Group
C0680251 (UMLS CUI)
Rheumatic disease other than RA
Item
rheumatic autoimmune disease other than RA
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0003873 (UMLS CUI [1,4])
History of or current inflammatory joint disease other than RA
Item
history of or current inflammatory joint disease other than RA
boolean
C0683381 (UMLS CUI [1,1])
C1705847 (UMLS CUI [1,2])
C0003873 (UMLS CUI [1,3])
C0262926 (UMLS CUI [1,4])
C0683381 (UMLS CUI [2,1])
C1705847 (UMLS CUI [2,2])
C0003873 (UMLS CUI [2,3])
C0521116 (UMLS CUI [2,4])
ACR
Item
functional class IV (ACR classification)
boolean
C0003873 (UMLS CUI [1,1])
C0598463 (UMLS CUI [1,2])
C0456387 (UMLS CUI [1,3])
Intraarticular or Parenteral Corticosteroids
Item
intraarticular or parenteral corticosteroids within 6 weeks prior to baseline
boolean
C4039704 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
C2064783 (UMLS CUI [2,1])
C0332185 (UMLS CUI [2,2])
Previous biologic agent
Item
previous treatment with a biologic agent for RA
boolean
C1531518 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial